Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growth.
Vernejoul, Fabienne
Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growth. [electronic resource] - Molecular therapy : the journal of the American Society of Gene Therapy Dec 2006 - 758-67 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1525-0016
10.1016/j.ymthe.2006.07.010 doi
Animals
Antimetabolites, Antineoplastic--metabolism
Apoptosis--drug effects
Cell Line, Tumor
Cell Survival--drug effects
Cricetinae
Deoxycytidine--analogs & derivatives
Deoxycytidine Kinase--genetics
Genetic Therapy--methods
Genetic Vectors--genetics
Male
Mesocricetus
Neoplasms, Experimental--therapy
Nucleoside-Phosphate Kinase--genetics
Pancreatic Neoplasms--pathology
Gemcitabine
Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growth. [electronic resource] - Molecular therapy : the journal of the American Society of Gene Therapy Dec 2006 - 758-67 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1525-0016
10.1016/j.ymthe.2006.07.010 doi
Animals
Antimetabolites, Antineoplastic--metabolism
Apoptosis--drug effects
Cell Line, Tumor
Cell Survival--drug effects
Cricetinae
Deoxycytidine--analogs & derivatives
Deoxycytidine Kinase--genetics
Genetic Therapy--methods
Genetic Vectors--genetics
Male
Mesocricetus
Neoplasms, Experimental--therapy
Nucleoside-Phosphate Kinase--genetics
Pancreatic Neoplasms--pathology
Gemcitabine